The development of a group B streptococcus prevention policy at a community hospital

Conrad J Clemens, E. Kaye Gable

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background and Objectives: In 1996, the Centers for Disease Control (CDC) issued guidelines for antepartum antibiotic prophylaxis of group B streptococcal (GBS) - positive women. The objective of this study is to document results of a GBS prophylaxis policy at one nonacademically affiliated, community hospital and discern its effectiveness with regard to compliance as well as in decreasing the incidence of early onset GBS (EOGBS) disease. Methods: The development of a GBS-prevention policy at the Women's Hospital of Greensboro (WHG) was documented by means of interviews and examination of minutes of meetings. Effectiveness of the policy was assessed by calculating the percentage of all GBS + or unknown mothers who received antepartum antibiotics during a 1-year period. Additionally, all newborns with any positive GBS culture the past 13 years at WHG were identified. Results: The policy was formulated and distributed during a 6-month period by strong leadership, community "buy-in," and an educational seminar. A preprinted physician order was written so that all GBS-positive/unknown mothers would receive antepartum antibiotics. Additionally, a clinical pathway was used to track and monitor maternal GBS status. During October 1, 1999 to September 30, 2000, 1124 (23.1%) mothers were found to be GBS positive/unknown. Of those who delivered an infant >37 weeks' gestation and who could be linked to the pulmonary database, 777 (91.1%) received antepartum antibiotics. The incidence of EOGBS disease at WHG before 1996 was 1.93 ± 0.7/1000 births compared to 0.4 ± 0.05/1000 after the issurance of the guidelines (p = 0.002, t-test). Conclusions: Over 90% of GBS-positive mothers were treated with antibiotics at WHG Associated with this high adherence rate to the CDC guidelines has been a five-fold decrease in the incidence of EOGBS disease. We attribute these results to the implementation of a preprinted physician order sheet to direct intrapartum antibiotics for women with GBS positive or unknown colonization and the use of a clinical pathway to track GBS colonization status.

Original languageEnglish (US)
Pages (from-to)523-525
Number of pages3
JournalJournal of perinatology : official journal of the California Perinatal Association
Volume22
Issue number7
DOIs
StatePublished - Oct 2002

Fingerprint

Streptococcus agalactiae
Community Hospital
Mothers
Anti-Bacterial Agents
Critical Pathways
Guidelines
Centers for Disease Control and Prevention (U.S.)
Incidence
Physicians
Antibiotic Prophylaxis
Compliance
Parturition
Newborn Infant
Databases
Interviews
Pregnancy
Lung

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

@article{b7abd7b863ac4d6288952b2b71037f50,
title = "The development of a group B streptococcus prevention policy at a community hospital",
abstract = "Background and Objectives: In 1996, the Centers for Disease Control (CDC) issued guidelines for antepartum antibiotic prophylaxis of group B streptococcal (GBS) - positive women. The objective of this study is to document results of a GBS prophylaxis policy at one nonacademically affiliated, community hospital and discern its effectiveness with regard to compliance as well as in decreasing the incidence of early onset GBS (EOGBS) disease. Methods: The development of a GBS-prevention policy at the Women's Hospital of Greensboro (WHG) was documented by means of interviews and examination of minutes of meetings. Effectiveness of the policy was assessed by calculating the percentage of all GBS + or unknown mothers who received antepartum antibiotics during a 1-year period. Additionally, all newborns with any positive GBS culture the past 13 years at WHG were identified. Results: The policy was formulated and distributed during a 6-month period by strong leadership, community {"}buy-in,{"} and an educational seminar. A preprinted physician order was written so that all GBS-positive/unknown mothers would receive antepartum antibiotics. Additionally, a clinical pathway was used to track and monitor maternal GBS status. During October 1, 1999 to September 30, 2000, 1124 (23.1{\%}) mothers were found to be GBS positive/unknown. Of those who delivered an infant >37 weeks' gestation and who could be linked to the pulmonary database, 777 (91.1{\%}) received antepartum antibiotics. The incidence of EOGBS disease at WHG before 1996 was 1.93 ± 0.7/1000 births compared to 0.4 ± 0.05/1000 after the issurance of the guidelines (p = 0.002, t-test). Conclusions: Over 90{\%} of GBS-positive mothers were treated with antibiotics at WHG Associated with this high adherence rate to the CDC guidelines has been a five-fold decrease in the incidence of EOGBS disease. We attribute these results to the implementation of a preprinted physician order sheet to direct intrapartum antibiotics for women with GBS positive or unknown colonization and the use of a clinical pathway to track GBS colonization status.",
author = "Clemens, {Conrad J} and Gable, {E. Kaye}",
year = "2002",
month = "10",
doi = "10.1038/sj.jp.7210794",
language = "English (US)",
volume = "22",
pages = "523--525",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - The development of a group B streptococcus prevention policy at a community hospital

AU - Clemens, Conrad J

AU - Gable, E. Kaye

PY - 2002/10

Y1 - 2002/10

N2 - Background and Objectives: In 1996, the Centers for Disease Control (CDC) issued guidelines for antepartum antibiotic prophylaxis of group B streptococcal (GBS) - positive women. The objective of this study is to document results of a GBS prophylaxis policy at one nonacademically affiliated, community hospital and discern its effectiveness with regard to compliance as well as in decreasing the incidence of early onset GBS (EOGBS) disease. Methods: The development of a GBS-prevention policy at the Women's Hospital of Greensboro (WHG) was documented by means of interviews and examination of minutes of meetings. Effectiveness of the policy was assessed by calculating the percentage of all GBS + or unknown mothers who received antepartum antibiotics during a 1-year period. Additionally, all newborns with any positive GBS culture the past 13 years at WHG were identified. Results: The policy was formulated and distributed during a 6-month period by strong leadership, community "buy-in," and an educational seminar. A preprinted physician order was written so that all GBS-positive/unknown mothers would receive antepartum antibiotics. Additionally, a clinical pathway was used to track and monitor maternal GBS status. During October 1, 1999 to September 30, 2000, 1124 (23.1%) mothers were found to be GBS positive/unknown. Of those who delivered an infant >37 weeks' gestation and who could be linked to the pulmonary database, 777 (91.1%) received antepartum antibiotics. The incidence of EOGBS disease at WHG before 1996 was 1.93 ± 0.7/1000 births compared to 0.4 ± 0.05/1000 after the issurance of the guidelines (p = 0.002, t-test). Conclusions: Over 90% of GBS-positive mothers were treated with antibiotics at WHG Associated with this high adherence rate to the CDC guidelines has been a five-fold decrease in the incidence of EOGBS disease. We attribute these results to the implementation of a preprinted physician order sheet to direct intrapartum antibiotics for women with GBS positive or unknown colonization and the use of a clinical pathway to track GBS colonization status.

AB - Background and Objectives: In 1996, the Centers for Disease Control (CDC) issued guidelines for antepartum antibiotic prophylaxis of group B streptococcal (GBS) - positive women. The objective of this study is to document results of a GBS prophylaxis policy at one nonacademically affiliated, community hospital and discern its effectiveness with regard to compliance as well as in decreasing the incidence of early onset GBS (EOGBS) disease. Methods: The development of a GBS-prevention policy at the Women's Hospital of Greensboro (WHG) was documented by means of interviews and examination of minutes of meetings. Effectiveness of the policy was assessed by calculating the percentage of all GBS + or unknown mothers who received antepartum antibiotics during a 1-year period. Additionally, all newborns with any positive GBS culture the past 13 years at WHG were identified. Results: The policy was formulated and distributed during a 6-month period by strong leadership, community "buy-in," and an educational seminar. A preprinted physician order was written so that all GBS-positive/unknown mothers would receive antepartum antibiotics. Additionally, a clinical pathway was used to track and monitor maternal GBS status. During October 1, 1999 to September 30, 2000, 1124 (23.1%) mothers were found to be GBS positive/unknown. Of those who delivered an infant >37 weeks' gestation and who could be linked to the pulmonary database, 777 (91.1%) received antepartum antibiotics. The incidence of EOGBS disease at WHG before 1996 was 1.93 ± 0.7/1000 births compared to 0.4 ± 0.05/1000 after the issurance of the guidelines (p = 0.002, t-test). Conclusions: Over 90% of GBS-positive mothers were treated with antibiotics at WHG Associated with this high adherence rate to the CDC guidelines has been a five-fold decrease in the incidence of EOGBS disease. We attribute these results to the implementation of a preprinted physician order sheet to direct intrapartum antibiotics for women with GBS positive or unknown colonization and the use of a clinical pathway to track GBS colonization status.

UR - http://www.scopus.com/inward/record.url?scp=0036772459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036772459&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7210794

DO - 10.1038/sj.jp.7210794

M3 - Article

C2 - 12368966

AN - SCOPUS:0036772459

VL - 22

SP - 523

EP - 525

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 7

ER -